BMY - Bristol-Myers Squibb Co.

BMY

$63.85 0.56 (-0.87%)

After Hours: $63.85 +0.00 (+0.00%)

Last updated: Sep 10, 2026 20:09

52-Week Range

$63.85

$42.52 $63.85 $68.64

Fundamentals Overview

Bristol-Myers Squibb Co. is near the high of its 52-week range with low valuation, trading relatively flat today.

Valuation low

P/E 14.2 P/B 5.27 P/S 2.67

Profitability

ROE 46.76% Net margin 18.9%

Risk (Beta)

0.19 — lower vol

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Hold — 46% confidence Risk: Lower Volatility — Beta 0.19. Diversify and only invest what you can afford to lose.

Supporting (Buy):

P/E 14.2 (value)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

$131.57B

P/E (TTM)

14.17

EPS (TTM)

N/A

Dividend Yield

4.58%

52-Week Range

$42.52 - $68.64

Volume vs Avg

N/A

Beta

0.19

About

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Sector: stocks

Headquarters:

Website: www.bms.com

Beta: 0.19 (Less volatile than market)

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

Metric	Value
Valuation
P/E (TTM)	14.17
PEG (TTM)	N/A
P/B (TTM)	5.27
P/S (TTM)	2.67
Profitability
ROE (TTM)	46.76%
ROA (TTM)	10.28%
Revenue growth (YoY)	N/A
Net margin (TTM)	18.87%
Gross margin (TTM)	71.66%
Operating margin (TTM)	25.51%
Debt to equity (TTM)	1.93

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for BMY.

Price target data is not available for this symbol from the current data source.

Stock Grades (Institutions)

No stock grades available for this symbol.

No price targets, ratings snapshot, or grades available for this symbol.